Skip to main content
. 2011 Mar 28;5:117. doi: 10.1186/1752-1947-5-117

Figure 1.

Figure 1

Changes of hemoglobin A1c (HbA1c) levels after adding sitagliptin to the ongoing therapeutic regimen. Sitagliptin was added at week 0. The changes of HbA1c levels of each patient were followed from 4 weeks prior to treatment (-4W) until 24 weeks after treatment.